118 related articles for article (PubMed ID: 12415720)
1. The hollow fiber assay.
Hall LA; Krauthauser CM; Wexler RS; Slee AM; Kerr JS
Methods Mol Med; 2003; 74():545-66. PubMed ID: 12415720
[No Abstract] [Full Text] [Related]
2. The hollow fiber assay: continued characterization with novel approaches.
Hall LA; Krauthauser CM; Wexler RS; Hollingshead MG; Slee AM; Kerr JS
Anticancer Res; 2000; 20(2A):903-11. PubMed ID: 10810375
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the relative cytotoxic effects of anticancer agents in serum-supplemented versus serum-free media using a tetrazolium colorimetric assay.
Tsai CM; Perng RP; Chang KT; Venzon D; Gazdar AF
Jpn J Cancer Res; 1996 Jan; 87(1):91-7. PubMed ID: 8609055
[TBL] [Abstract][Full Text] [Related]
4. Correlation of drug response in human tumors histocultured in vitro with an image-analysis MTT end point and in vivo xenografted in nude mice.
Colangelo D; Guo HY; Connors KM; Kubota T; Silvestro L; Hoffman RM
Anticancer Res; 1992; 12(5):1373-6. PubMed ID: 1444193
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a direct relationship between the increase in the in vitro passage number of human non-small-cell-lung cancer primocultures and their chemosensitivity.
Kruczynski A; Kiss R
Anticancer Res; 1993; 13(2):507-13. PubMed ID: 7685990
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a human tumour cell line panel for screening of anti-tumour agents in vitro.
Fricker SP; Buckley RG
Biochem Soc Trans; 1989 Dec; 17(6):1049-50. PubMed ID: 2628072
[No Abstract] [Full Text] [Related]
7. VIP inhibits the proliferation of small-cell and nonsmall-cell lung carcinoma.
Maruno K; Said SI
Ann N Y Acad Sci; 1996 Dec; 805():389-92; discussion 392-3. PubMed ID: 8993419
[No Abstract] [Full Text] [Related]
8. Predictability of in vivo chemosensitivity by in vitro MTT assay with reference to the clonogenic assay.
Shimoyama Y; Kubota T; Watanabe M; Ishibiki K; Abe O
J Surg Oncol; 1989 May; 41(1):12-8. PubMed ID: 2716329
[TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines.
Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR
J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137
[TBL] [Abstract][Full Text] [Related]
10. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
Sobottka SB; Berger MR
Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
[TBL] [Abstract][Full Text] [Related]
11. Comparison of chemosensitivity tests: clonogenic assay versus MTT assay.
Kawada K; Yonei T; Ueoka H; Kiura K; Tabata M; Takigawa N; Harada M; Tanimoto M
Acta Med Okayama; 2002 Jun; 56(3):129-34. PubMed ID: 12108583
[TBL] [Abstract][Full Text] [Related]
12. [New approaches in experimental cancerology: in search of therapeutic models].
Guilbaud N; Kraus-Berthier L; Meyer-Losic F; Pierré A; Hickman J
Bull Cancer; 2001 Jan; 88(1):75-84. PubMed ID: 11182656
[No Abstract] [Full Text] [Related]
13. FK317, a novel substituted dihydrobenzoxazine, exhibits potent antitumor activity against human tumor xenografts in nude mice.
Naoe Y; Inami M; Matsumoto S; Takagaki S; Fujiwara T; Yamazaki S; Kawamura I; Nishigaki F; Tsujimoto S; Manda T; Shimomura K
Jpn J Cancer Res; 1998 Dec; 89(12):1306-17. PubMed ID: 10081492
[TBL] [Abstract][Full Text] [Related]
14. Chemosensitivity testing of fresh human leukemia cells using both a dye exclusion assay and a tetrazolium dye (MTT) assay.
Kirkpatrick DL; Duke M; Goh TS
Leuk Res; 1990; 14(5):459-66. PubMed ID: 2345469
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the hollow fiber assay for the determination of microtubule disruption in vivo.
Suggitt M; Swaine DJ; Pettit GR; Bibby MC
Clin Cancer Res; 2004 Oct; 10(19):6677-85. PubMed ID: 15475458
[TBL] [Abstract][Full Text] [Related]
16. The clinical benefit of the histoculture drug response assay.
Hoffman RM
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():321-2. PubMed ID: 10895174
[No Abstract] [Full Text] [Related]
17. Chemosensitivity testing of human lung cancer cell lines using the MTT assay.
Carmichael J; Mitchell JB; DeGraff WG; Gamson J; Gazdar AF; Johnson BE; Glatstein E; Minna JD
Br J Cancer; 1988 Jun; 57(6):540-7. PubMed ID: 2841961
[TBL] [Abstract][Full Text] [Related]
18. In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
Horiuchi N; Nakagawa K; Sasaki Y; Minato K; Fujiwara Y; Nezu K; Ohe Y; Saijo N
Cancer Chemother Pharmacol; 1988; 22(3):246-50. PubMed ID: 2842080
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tetrazolium colorimetric and [3H]-uridine assays for in vitro chemosensitivity testing.
Ford CH; Richardson VJ; Tsaltas G
Cancer Chemother Pharmacol; 1989; 24(5):295-301. PubMed ID: 2788039
[TBL] [Abstract][Full Text] [Related]
20. The MTT assay for chemosensitivity testing of human tumors of the central nervous system. Part I: Evaluation of test-specific variables.
Nikkhah G; Tonn JC; Hoffmann O; Kraemer HP; Darling JL; Schönmayr R; Schachenmayr W
J Neurooncol; 1992 May; 13(1):1-11. PubMed ID: 1613535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
